Business Segments Abbott Laboratories Swiss Exchange
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.00 CHF | +0.71% |
|
-2.07% | -28.28% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Therapeutic Devices | ||||||||||
Medical Devices | 14.37B | 14.69B | 16.89B | 18.99B | 21.39B | |||||
Total Assets | 7.26B | 7.84B | 9.03B | 9.47B | 10.69B | |||||
CAPEX | -348M | -335M | -604M | -630M | -658M | |||||
D&A | 285M | 311M | 315M | 343M | 378M | |||||
Operating Income | 4.51B | 4.41B | 5.31B | 6.15B | 7.21B | |||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Diagnostics | 15.64B | 16.58B | 9.99B | 9.34B | 8.94B | |||||
Total Assets | 7.7B | 7.98B | 7.77B | 7.68B | 8.27B | |||||
CAPEX | -980M | -832M | -750M | -758M | -761M | |||||
D&A | 760M | 494M | 499M | 521M | 533M | |||||
Operating Income | 6.26B | 6.67B | 2.43B | 2.07B | 1.74B | |||||
Vitamins and Nutritional Supplements | ||||||||||
Nutrition | 8.29B | 7.46B | 8.15B | 8.41B | 8.45B | |||||
Total Assets | 3.42B | 3.62B | 4.27B | 4.4B | 4.79B | |||||
CAPEX | -174M | -251M | -457M | -382M | -302M | |||||
D&A | 151M | 155M | 155M | 159M | 175M | |||||
Operating Income | 1.76B | 706M | 1.33B | 1.5B | 1.56B | |||||
Pharmaceutical Products | ||||||||||
Established Pharmaceutical | 4.72B | 4.91B | 5.07B | 5.19B | 5.54B | |||||
Total Assets | 2.79B | 2.88B | 3.12B | 3.09B | 3.54B | |||||
CAPEX | -169M | -175M | -185M | -183M | -169M | |||||
D&A | 94M | 97M | 104M | 96M | 101M | |||||
Operating Income | 889M | 1.05B | 1.21B | 1.23B | 1.29B | |||||
Optical Healthcare | ||||||||||
Other | 52M | 11M | 14M | 16M | 17M | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | -201M | -182M | -213M | -292M | -259M | |||||
D&A | 201M | 197M | 204M | 221M | 247M | |||||
Operating Income | - | - | - | - | - | |||||
Operating Income | -801M | -509M | -308M | -422M | -157M | |||||
Operating Income | -2.05B | -2.01B | -1.97B | -1.88B | -1.68B | |||||
Operating Income | -640M | -685M | -644M | -673M | -664M | |||||
Total Assets | 35.97B | 33.25B | 32.49B | 29.76B | 29.56B | |||||
Total Assets | 6.99B | 7.91B | 8.46B | 18.16B | 20B | |||||
Total Assets | 11.06B | 10.94B | 8.08B | 8.85B | 9.86B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 16.64B | 18.14B | 15.45B | 16.32B | 17.13B | |||||
Total Assets | 6.8B | 7.7B | 8.9B | 10.3B | 11.9B | |||||
All Other Countries | 15.52B | 14.84B | 14.08B | 14.85B | 15.98B | |||||
Germany | 2.57B | 2.34B | 2.34B | 2.54B | 2.76B | |||||
China | 2.39B | 2.13B | 2.25B | 2.11B | 1.91B | |||||
Switzerland | 1.31B | 1.34B | 1.64B | 1.75B | 1.87B | |||||
India | 1.56B | 1.65B | 1.75B | 1.82B | 1.87B | |||||
Japan | 1.7B | 1.93B | 1.51B | 1.44B | 1.48B | |||||
United Kingdom | - | - | - | - | 1.34B | |||||
Vietnam | - | - | - | - | - | |||||
Colombia | - | - | - | - | - | |||||
Russia | - | - | - | - | - | |||||
Brazil | - | - | - | - | - | |||||
France | - | - | - | - | - | |||||
Italy | - | - | - | - | - | |||||
Total Assets | 6.3B | 6.5B | 7.3B | 8.2B | 10.3B | |||||
The Netherlands | - | - | 1.07B | 1.12B | - | |||||
Canada | 1.38B | 1.28B | - | - | - |
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
- Financials Abbott Laboratories
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
